BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
4/13/2023 8:14:59 AM | Browse: 227 | Download: 804
 |
Received |
|
2022-11-28 11:45 |
|
Peer-Review Started |
|
2022-11-28 11:45 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2022-12-20 03:12 |
|
Revised |
|
2022-12-29 10:17 |
|
Second Decision |
|
2023-03-08 03:12 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2023-03-13 17:15 |
|
Articles in Press |
|
2023-03-13 17:15 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2023-04-04 00:37 |
|
Publish the Manuscript Online |
|
2023-04-13 08:14 |
| ISSN |
1007-9327 (print) and 2219-2840 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2023. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Basic Study |
| Article Title |
Anti-inflammatory effect and antihepatoma mechanism of carrimycin
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Xiu-Yan Li, Yu-Ting Luo, Yan-Hong Wang, Zhi-Xin Yang, Yu-Zhou Shang and Qing-Xia Guan |
| ORCID |
|
| Funding Agency and Grant Number |
| Funding Agency |
Grant Number |
| Heilongjiang Natural Science Foundation |
LH2022H085, H2016057 |
| Scientific Research Project of Heilongjiang Health Committee |
2020-293 |
|
| Corresponding Author |
Qing-Xia Guan, PhD, Teacher, Key Laboratory of Basic and Application Research of Beiyao, Heilongjiang University of Chinese Medicine, No. 24 Heping Road, Xiangfang District, Harbin 150040, Heilongjiang Province, China. 546105832@qq.com |
| Key Words |
Carrimycin; Reverse molecular docking; Network pharmacology; Liver cancer; Anti-inflammatory; Anti-hepatoma |
| Core Tip |
Although some studies have shown that carrimycin (CAM) has therapeutic effects on inflammation and liver cancer, there are few experimental studies on its component analysis and mechanism of action. The mechanism of action was predicted by reverse molecular docking between the liver cancer target and CAM. By establishing an inflammatory mouse model to assess the state of inflammatory factors after administration, we further proved the therapeutic effect of CAM on inflammation and its possible mechanism in the treatment of liver cancer. |
| Publish Date |
2023-04-13 08:14 |
| Citation |
Li XY, Luo YT, Wang YH, Yang ZX, Shang YZ, Guan QX. Anti-inflammatory effect and antihepatoma mechanism of carrimycin. World J Gastroenterol 2023; 29(14): 2134-2152 |
| URL |
https://www.wjgnet.com/1007-9327/full/v29/i14/2134.htm |
| DOI |
https://dx.doi.org/10.3748/wjg.v29.i14.2134 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
